174 related articles for article (PubMed ID: 36988342)
1. Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile.
Adorno Febles VR; Hao Y; Ahsan A; Wu J; Qian Y; Zhong H; Loeb S; Makarov DV; Lepor H; Wysock J; Taneja SS; Huang WC; Becker DJ; Balar AV; Melamed J; Deng FM; Ren Q; Kufe D; Wong KK; Adeegbe DO; Deng J; Wise DR
Prostate; 2023 Jun; 83(9):840-849. PubMed ID: 36988342
[TBL] [Abstract][Full Text] [Related]
2. Agent Orange as a risk factor for high-grade prostate cancer.
Ansbaugh N; Shannon J; Mori M; Farris PE; Garzotto M
Cancer; 2013 Jul; 119(13):2399-404. PubMed ID: 23670242
[TBL] [Abstract][Full Text] [Related]
3. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
[TBL] [Abstract][Full Text] [Related]
4. TOX-expressing terminally exhausted tumor-infiltrating CD8
Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
[TBL] [Abstract][Full Text] [Related]
5. Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy?
Elshafei A; Moussa AS; Hatem A; Ethan V; Panumatrassamee K; Hernandez AV; Jones JS
Urology; 2013 Apr; 81(4):826-30. PubMed ID: 23434102
[TBL] [Abstract][Full Text] [Related]
6. CD226 identifies functional CD8
Huang H; Huang Z; Ge J; Yang J; Chen J; Xu B; Wu S; Zheng X; Chen L; Zhang X; Jiang J
Front Immunol; 2023; 14():1150803. PubMed ID: 37056782
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma: the significance of CD8
Zhu Q; Yang Y; Chen K; Zhang Q; Huang Y; Jian S
J Transl Med; 2024 Feb; 22(1):174. PubMed ID: 38369502
[TBL] [Abstract][Full Text] [Related]
8. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
[TBL] [Abstract][Full Text] [Related]
9. Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (≥ct2) patients.
Yilmaz H; Ustuner M; Ciftci S; Yavuz U; Ozkan TA; Dillioglugil O
Int Braz J Urol; 2014; 40(5):613-9. PubMed ID: 25498272
[TBL] [Abstract][Full Text] [Related]
10. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8
Ge Z; Zhou G; Campos Carrascosa L; Gausvik E; Boor PPC; Noordam L; Doukas M; Polak WG; Terkivatan T; Pan Q; Takkenberg RB; Verheij J; Erdmann JI; IJzermans JNM; Peppelenbosch MP; Kraan J; Kwekkeboom J; Sprengers D
Cell Mol Gastroenterol Hepatol; 2021; 12(2):443-464. PubMed ID: 33781741
[TBL] [Abstract][Full Text] [Related]
11. Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.
Sfanos KS; Bruno TC; Meeker AK; De Marzo AM; Isaacs WB; Drake CG
Prostate; 2009 Nov; 69(15):1694-703. PubMed ID: 19670224
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral CXCL13
Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of intratumoral CD8+ regulatory T cells in prostate carcinoma.
Compérat E; Egevad L; Camparo P; Roupret M; Vaessen C; Valdman A; Jonmarker S; Capron F; Cussenot O; Charlotte F
Anal Quant Cytol Histol; 2010 Feb; 32(1):39-44. PubMed ID: 20701086
[TBL] [Abstract][Full Text] [Related]
14. Non-Invasive Diagnosis of Prostate Cancer and High-Grade Prostate Cancer Using Multiparametric Ultrasonography and Serological Examination.
Li J; Zhu C; Yang S; Mao Z; Lin S; Huang H; Xu S
Ultrasound Med Biol; 2024 Apr; 50(4):600-609. PubMed ID: 38238199
[TBL] [Abstract][Full Text] [Related]
15. Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor).
Siddiqui BA; Chapin BF; Jindal S; Duan F; Basu S; Yadav SS; Gu AD; Espejo AB; Kinder M; Pettaway CA; Ward JF; Tidwell RSS; Troncoso P; Corn PG; Logothetis CJ; Knoblauch R; Hutnick N; Gottardis M; Drake CG; Sharma P; Subudhi SK
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36948506
[TBL] [Abstract][Full Text] [Related]
16. High intratumoral CD8
Yang Y; Attwood K; Bshara W; Mohler JL; Guru K; Xu B; Kalinski P; Chatta G
Prostate; 2021 Jan; 81(1):20-28. PubMed ID: 33085799
[TBL] [Abstract][Full Text] [Related]
17. A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes.
Calagua C; Ficial M; Jansen CS; Hirz T; Del Balzo L; Wilkinson S; Lake R; Ku AT; Voznesensky O; Sykes DB; Saylor PJ; Ye H; Signoretti S; Kissick H; Sowalsky AG; Balk SP; Einstein DJ
Clin Cancer Res; 2021 Sep; 27(17):4836-4847. PubMed ID: 34168052
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
19. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
20. Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese Population.
Fang D; Zhao C; Ren D; Yu W; Wang R; Wang H; Li X; Yin W; Yu X; Yang K; Liu P; Shan G; Li S; He Q; Wang X; Xin Z; Zhou L
Ann Surg Oncol; 2016 Dec; 23(13):4284-4292. PubMed ID: 27464612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]